ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,544.10
2.53%
S&P 500
5,275.03
-0.16%
Dow Jones
38,644.84
0.19%
US Dollar vs Yen
154.664
-0.91%
Brent Oil
77.805
-0.43%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. CNBX Pharmaceuticals Inc (QB) (CNBX)

  7. CNBX Pharmaceuticals Inc (QB) (CNBX) ニュース

CNBX

CNBX Pharmaceuticals (QB) (CNBX)

CNBX Pharmaceuticals Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:CNBX
日付受信時刻ニュースソース見出しコード企業名
2024/02/1406 : 27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2024/01/1300 : 13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2023/07/1423 : 28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2023/04/1422 : 59Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2023/03/0707 : 04Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2023/02/0821 : 51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2023/01/1322 : 41Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/12/3004 : 52Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/12/2721 : 50Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/07/2601 : 12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/07/1421 : 03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/04/1222 : 58Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/03/1619 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/02/1906 : 02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/02/1722 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/02/0422 : 26Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2022/01/1403 : 07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/11/2004 : 52Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/09/1322 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/07/2004 : 48Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/07/1504 : 51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/07/0701 : 24Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/05/1819 : 07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/05/1023 : 41Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/04/2820 : 47Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/04/1501 : 43Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/03/1220 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/02/2405 : 28Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2021/01/1506 : 03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
2020/12/2122 : 55Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:CNBX

最近閲覧した銘柄

NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
COIN
SOLUSD
Solana
NYSE
AXP
American Express
CCOM
SILVER
SILVER
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
AMEX
SPY
SPDR S&P 500
CCOM
US30
US 30
NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有